Commission Implementing Decision (EU) 2022/2326 of 24 November 2022 not approving epsilon-metofluthrin as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
086/2023 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2022/2326 of 24 November 2022 not approving epsilon-metofluthrin as an active substance for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsbeschluss (EU) 2022/2326 der Kommission vom 24. November 2022 zur Nichtgenehmigung von Epsilon-metofluthrin als Wirkstoff zur Verwendung in Biozidprodukten der Produktart 19 gemäß der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates
History
29.04.2023
Adopted JCD confirmed entry into force date
29.04.2023
Compliance date in the EEA
28.04.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
15.02.2023
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
24.11.2022
Adoption date in the EU
18.12.2022
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.